RxDoctor Payments Data

Paul Merkel, DPM

Podiatrist · Rochester, NYNPI 1932203577

Payments from drug & device makers

What this record shows

30 manufacturers reported payments, led by Prodigy Surgical Distribution, Inc. at 47.0% of the total. Reporting peaked in 2021 at $4,179 and has fallen 72.3% since, to $1,156 in 2025. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,379in general payments, 2019–2025

Across 107 payments — averaging $97.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Prodigy Surgical Distribution, Inc.$5K
  • Organogenesis Inc.$829
  • Treace Medical Concepts, Inc.$726
  • Smith+Nephew$647
  • Integra Lifesciences Corporation$610
  • Stryker$403
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$5,42652%
  • Education$4,95348%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,379 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$38,251
Medicare patients
197
Services billed
470

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole19$18,461
Clotrimazole208$5,400
Ciclopirox73$4,139
Diclofenac Sodium122$3,348
Econazole Nitrate34$1,964
Ketoconazole24$1,069
Lidocaine44$840
Colchicine40$732
Lidocaine-PrilocaineLidocaine/Prilocaine22$707
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav47$564
Cephalexin73$530
CiclopiroxCiclopirox Olamine27$517
Nabumetone29$401
Triamcinolone Acetonide32$347
Meloxicam129$281

Paid to pharmacies, not to this prescriber.

Other podiatrist in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →